References
- Maor E, Ivorra A, Mitchell JJ, et al. Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol. 2010;21(11):1708–1715.
- Lee EW, Thai S, Kee ST. Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver. 2010;4(Suppl 1):S99–S104.
- Lee EW, Wong D, Prikhodko SV, et al. Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes. J Vasc Interv Radiol. 2012;23(1):107–113.
- Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality-clinical implications. Technol Cancer Res Treat. 2007;6(1):37–48.
- Deodhar A, Monette S, Single GW, Jr, et al. Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology. 2011;77(3):754–760.
- Lee EW, Chen C, Prieto VE, et al. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology. 2010;255(2):426–433.
- Li W, Fan Q, Ji Z, et al. The effects of irreversible electroporation (IRE) on nerves. PLoS One. 2011;6(4):e18831 201114.
- Gordon T, Sulaiman OA, Ladak A. Chapter 24: electrical stimulation for improving nerve regeneration: where do we stand? Int Rev Neurobiol. 2009;87:433–444.
- Schoellnast H, Monette S, Ezell PC, et al. Acute and subacute effects of irreversible electroporation on nerves: experimental study in a pig model. Radiology. 2011;260(2):421–427.
- Schoellnast H, Monette S, Ezell PC, et al. The delayed effects of irreversible electroporation ablation on nerves. Eur Radiol. 2013;23(2):375–380.
- Luo X, Qin Z, Tao H, et al. The safety of irreversible electroporation on nerves adjacent to treated tumors. World Neurosurg. 2017;108:642–649.
- Wong SS, Hui JW, Chan AW, et al. Irreversible electroporation of the femoral neurovascular bundle: imaging and histologic evaluation in a Swine Model. J Vasc Interv Radiol. 2015;26(8):1212–1220.e1.
- Martin RC. Irreversible electroporation of locally advanced pancreatic head adenocarcinoma. J Gastrointest Surg. 2013;17(10):1850–1856.
- Eidelberg E. Letter: grading animals with spinal cord injury. J Neurosurg. 1975;43(5):646–647.
- Aoun HD, Littrup PJ, Jaber M, et al. Percutaneous cryoablation of renal tumors: is it time for a new paradigm shift? J Vasc Interv Radiol. 2017;28(10):1363–1370.
- Song KD. Percutaneous cryoablation for hepatocellular carcinoma. Clin Mol Hepatol. 2016;22(4):509–515.
- Cazzato RL, Garnon J, Ramamurthy N, et al. Percutaneous image-guided cryoablation: current applications and results in the oncologic field. Med Oncol. 2016;33(12):140.
- Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2016;32(3):339–344.
- Casadei R, Ricci C, Pezzilli R, et al. A prospective study on radiofrequency ablation locally advanced pancreatic cancer. Hbpd Int. 2010;9(3):306–311.
- Girelli R, Frigerio I, Salvia R, et al. Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer. Br J Surg. 2010;97(2):220–225.
- Philip A, Gupta S, Ahrar K, et al. A spectrum of nerve injury after thermal ablation: a report of four cases and review of the literature. Cardiovasc Intervent Radiol. 2013;36(5):1427–1435.
- Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–231.
- Onik G, Mikus P, Rubinsky B. Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat. 2007;6(4):295–300.
- Son YJ, Thompson WJ. Schwann cell processes guide regeneration of peripheral axons. Neuron. 1995;14(1):125–132.
- Shen J, Zhou CP, Zhong XM, et al. MR neurography: T1 and T2 measurements in acute peripheral nerve traction injury in rabbits. Radiology. 2010;254(3):729–738.
- Rubinsky J, Onik G, Mikus P, et al. Optimal parameters for the destruction of prostate cancer using irreversible electroporation. J Urol. 2008;180(6):2668–2674.
- Miller L, Leor J, Rubinsky B. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat. 2005;4(6):699–705.
- Al-Sakere B, Andre F, Bernat C, et al. Tumor ablation with irreversible electroporation. PLoS One. 2007;2(11):e1135.
- Narayanan G, Hosein PJ, Arora G, et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol. 2012;23(12):1613–1621.
- Martin RC, 2nd, Kwon D, Chalikonda S, et al. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg. 2015;262(3):486–494.
- Martin RC, 2nd, McFarland K, Ellis S, et al. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg. 2012;215(3):361–369.
- Edd JF, Davalos RV. Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat. 2007;6(4):275–286.
- Yılmaz S, Özdoğan M, Cevener M, et al. Use of cryoablation beyond the prostate. Insights Imaging. 2016;7(2):223–232.
- Bunch TJ, Bruce GK, Mahapatra S, et al. Mechanisms of phrenic nerve injury during radiofrequency ablation at the pulmonary vein orifice. J Cardiovasc Electrophysiol. 2005;16(12):1318–1325.